The background and rationale for a new fixed-dose combination for first-line treatment of tuberculosis in children-Reference-Cited by-同舟云学术

The background and rationale for a new fixed-dose combination for first-line treatment of tuberculosis in children

Published:2015-12-01 Issue:12 Volume:19 Page:3-8
ISSN:1027-3719
Container-title:The International Journal of Tuberculosis and Lung Disease
language:en
Short-container-title:int j tuberc lung dis

Author:

Graham S. M.¹,Grzemska M.²,Gie R. P.³

Affiliation:

1. Centre for International Child Health, University of Melbourne Department of Paediatrics and Murdoch Children's Research Institute, Royal Children's Hospital, Melbourne, Victoria, Australia

2. Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland

3. Department of Paediatrics and Child Health, Stellenbosch University, Tygerberg Children's Hospital, Cape Town, South Africa

Publisher

International Union Against Tuberculosis and Lung Disease

Subject

Infectious Diseases,Pulmonary and Respiratory Medicine

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pill Burden: A Major Barrier to HAART Adherence and Fixed Dose Combinations (FDCS) as its Solution – A Mini-Review;Current HIV Research;2024-05

2. Profiling of 3-Formyl rifamycin (3-FR) from sintered fixed dose combinations (SDC) of rifampicin and isoniazid by using RP-HPLC, LC-ESI-QTOF and UPLC/MS/MS;Microchemical Journal;2024-02

3. Adequacy of WHO weight-band dosing and fixed-dose combinations for the treatment of TB in children;The International Journal of Tuberculosis and Lung Disease;2023-05-01

4. Toward a conceptual framework of the acceptability of tuberculosis treatment in children using a theory generative approach;PLOS Global Public Health;2022-12-22

5. Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children;New England Journal of Medicine;2022-03-10